ZAP-70 is a nonreceptor protein tyrosine kinase that is essential for signaling via the T cell antigen receptor (TCR). ZAP-70 becomes phosphorylated and activated by LCK protein tyrosine kinase after interaction of its two NH2-terminal SH2 domains with tyrosine-phosphorylated subunits of the activated TCR. In this study, the localization of ZAP-70 was investigated by immunofluorescence and confocal microscopy. ZAP-70 was found to be localized to the cell cortex in a diffuse band under the plasma membrane in unstimulated T cells, and this localization was not detectably altered by TCR stimulation. Analysis of mutants indicated that ZAP-70 targeting was independent of its SH2 domains but required its active kinase domain. The specific compartmentalization of ZAP-70 suggests that it may interact with an anchoring protein in the cell cortex via its hinge or kinase domains. It is likely that the maintenance of high concentrations of ZAP-70 at the cell cortex, that only has to move a short distance to interact with phophorylated TCR subunits, facilitates rapid initiation of signaling by the TCR. In addition, as the major increase in tyrosine phosphorylation induced by the TCR also occurs at the cell cortex (Ley, S.C., M. Marsh, C.R. Bebbington, K. Proudfoot, and P. Jordan. 1994. J. Cell. Biol. 125:639–649), ZAP-70 may be localized close to its downstream targets.
Skip Nav Destination
Article navigation
30 June 1997
Article|
June 30 1997
ZAP-70 Protein Tyrosine Kinase Is Constitutively Targeted to the T Cell Cortex Independently of its SH2 Domains
Russell D.J. Huby,
Russell D.J. Huby
*Division of Cellular Immunology, National Institute for Medical Research, London NW7 1AA, United Kingdom; ‡Mitsubishi Chemical Corporation, Mitsubishi Kasei Institute of Life Sciences, Machida, Tokyo 194, Japan; and §Howard Hughes Medical Institute, Department of Medicine, and Department of Microbiology and Immunology, University of California, San Francisco, California 94143
Search for other works by this author on:
Makio Iwashima,
Makio Iwashima
*Division of Cellular Immunology, National Institute for Medical Research, London NW7 1AA, United Kingdom; ‡Mitsubishi Chemical Corporation, Mitsubishi Kasei Institute of Life Sciences, Machida, Tokyo 194, Japan; and §Howard Hughes Medical Institute, Department of Medicine, and Department of Microbiology and Immunology, University of California, San Francisco, California 94143
Search for other works by this author on:
Arthur Weiss,
Arthur Weiss
*Division of Cellular Immunology, National Institute for Medical Research, London NW7 1AA, United Kingdom; ‡Mitsubishi Chemical Corporation, Mitsubishi Kasei Institute of Life Sciences, Machida, Tokyo 194, Japan; and §Howard Hughes Medical Institute, Department of Medicine, and Department of Microbiology and Immunology, University of California, San Francisco, California 94143
Search for other works by this author on:
Steven C. Ley
Steven C. Ley
*Division of Cellular Immunology, National Institute for Medical Research, London NW7 1AA, United Kingdom; ‡Mitsubishi Chemical Corporation, Mitsubishi Kasei Institute of Life Sciences, Machida, Tokyo 194, Japan; and §Howard Hughes Medical Institute, Department of Medicine, and Department of Microbiology and Immunology, University of California, San Francisco, California 94143
Search for other works by this author on:
Russell D.J. Huby
*Division of Cellular Immunology, National Institute for Medical Research, London NW7 1AA, United Kingdom; ‡Mitsubishi Chemical Corporation, Mitsubishi Kasei Institute of Life Sciences, Machida, Tokyo 194, Japan; and §Howard Hughes Medical Institute, Department of Medicine, and Department of Microbiology and Immunology, University of California, San Francisco, California 94143
Makio Iwashima
*Division of Cellular Immunology, National Institute for Medical Research, London NW7 1AA, United Kingdom; ‡Mitsubishi Chemical Corporation, Mitsubishi Kasei Institute of Life Sciences, Machida, Tokyo 194, Japan; and §Howard Hughes Medical Institute, Department of Medicine, and Department of Microbiology and Immunology, University of California, San Francisco, California 94143
Arthur Weiss
*Division of Cellular Immunology, National Institute for Medical Research, London NW7 1AA, United Kingdom; ‡Mitsubishi Chemical Corporation, Mitsubishi Kasei Institute of Life Sciences, Machida, Tokyo 194, Japan; and §Howard Hughes Medical Institute, Department of Medicine, and Department of Microbiology and Immunology, University of California, San Francisco, California 94143
Steven C. Ley
*Division of Cellular Immunology, National Institute for Medical Research, London NW7 1AA, United Kingdom; ‡Mitsubishi Chemical Corporation, Mitsubishi Kasei Institute of Life Sciences, Machida, Tokyo 194, Japan; and §Howard Hughes Medical Institute, Department of Medicine, and Department of Microbiology and Immunology, University of California, San Francisco, California 94143
1. Abbreviations used in this paper: ITAM, immunoreceptor tyrosine-based activation motifs; PTK, protein tyrosine kinase; TCR, T cell antigen receptor.
Please address all correspondence to Steven C. Ley, Division of Cellular Immunology, National Institute for Medical Research, Mill Hill, London NW7 1AA, UK. Tel.: (44) 181-913-8589; Fax: (44) 181-906-4477.
Received:
February 27 1997
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1997
J Cell Biol (1997) 137 (7): 1639–1649.
Article history
Received:
February 27 1997
Citation
Russell D.J. Huby, Makio Iwashima, Arthur Weiss, Steven C. Ley; ZAP-70 Protein Tyrosine Kinase Is Constitutively Targeted to the T Cell Cortex Independently of its SH2 Domains. J Cell Biol 30 June 1997; 137 (7): 1639–1649. doi: https://doi.org/10.1083/jcb.137.7.1639
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement